pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07144826: Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

    Sponsor: Ohio State University Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma, Stage II Ovarian Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06206226: The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Depression, Depressive Disorder, Depressive Symptoms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05116085: Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer

    Sponsor: BeiGene. Phase: PHASE2. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512115: The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surgery?

    Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: NA. Conditions: Myopia, Refractive Ametropia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07532915: A Multicenter, Prospective, Randomized Controlled Study on EUS-Guided Precise Disconnection of Varices Versus Endoscopic Gastric Variceal Glue Injection for the Prevention of Gastric Variceal Bleeding.

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Gastric Variceal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00893035: Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients

    Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: . Conditions: Breast Cancer, Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07324408: Multiple Ascending Dose Study of NH102 in Healthy Subjects

    Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06760208: A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

    Sponsor: Pfizer. Phase: . Conditions: Pneumococcal Immunization, Safety

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07337408: Characterization of Weaning Practices in ICUs of Global South Countries

    Sponsor: Hospital do Coracao. Phase: . Conditions: Weaning From Mechanical Ventilation, Weaning Failure, Weaning From Mechanical Ventilation, Extubation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07542925: Prediction of Postoperative ICU Requirement in Oncologic Surgery

    Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Neoplasms, Postoperative Complications, Perioperative/Postoperative Complications, Intensive Care Units

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07232576: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis

    Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Adult Patients With Moderately to Severely Active Ulcerative Colitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06357676: Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

    Sponsor: OHSU Knight Cancer Institute. Phase: PHASE1. Conditions: Mantle Cell Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07038317: A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status

    Sponsor: University of Hawaii. Phase: NA. Conditions: Vaping Behaviors, Message Exposure, Young Adults

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06614140: Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

    Sponsor: Seqker Biosciences, Inc.. Phase: PHASE1. Conditions: Cancer, Solid Tumor, Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07323589: Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

    Sponsor: PAEC general hospital. Phase: PHASE3. Conditions: PCOS (Polycystic Ovary Syndrome)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07202650: THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME

    Sponsor: Baskent University. Phase: NA. Conditions: Guided Imagery, Premenstrual Syndrome, Nursing

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01765374: Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

    Sponsor: University Hospital, Rouen. Phase: PHASE4. Conditions: Rheumatoid Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05436418: The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04626518: Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Carcinoma, Renal Cell

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07074418: Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE4. Conditions: Chronic Kidney Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06121297: RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    Sponsor: Cabaletta Bio. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus, Lupus Nephritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07314710: Factors Affecting Postural Awareness in Academics

    Sponsor: Kutahya Health Sciences University. Phase: . Conditions: Health Adult Subjects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07478913: Predictive Value of Endobronchial Sonographic Patterns in Diagnosis of Mediastinal Lymphadenopathy

    Sponsor: Ain Shams University. Phase: . Conditions: Endobronchial Sonographic Patterns

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07427420: Postoperative Pain After Pulpectomy in Primary Molars

    Sponsor: Cairo University. Phase: NA. Conditions: Irreversible Pulpitis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06487858: A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

    Sponsor: BeOne Medicines. Phase: PHASE1. Conditions: Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07343258: Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline

    Sponsor: University Ghent. Phase: NA. Conditions: Suicide, Suicidal Ideation and Behavior, Crisis Intervention

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06652958: A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV

    Sponsor: ViiV Healthcare. Phase: PHASE1. Conditions: HIV Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04450758: Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma

    Sponsor: Skane University Hospital. Phase: . Conditions: Colon Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03726658: Zelquistinel in the Treatment of Adults With Major Depressive Disorder

    Sponsor: Syndeio Biosciences, Inc. Phase: PHASE1. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05272826: Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

    Sponsor: Canadian Myeloma Research Group. Phase: PHASE2. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05934526: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

    Sponsor: GB002, Inc.. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07101926: Monitoring of Anti-TFPI in Hemophilia

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Hemophilia, Rebalancing Agents, Prophylaxis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03283878: Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial

    Sponsor: Duke University. Phase: PHASE4. Conditions: Arthropathy of Knee, Antibiotic Prophylaxis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04227678: Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency

    Sponsor: Université de Sherbrooke. Phase: NA. Conditions: Lipoprotein Lipase Deficiency

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT00426985: Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

    Sponsor: APR Applied Pharma Research s.a.. Phase: PHASE3. Conditions: Tendonitis, Bursitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03832985: Pediatric Reporting of Adult-Onset Genomic Results

    Sponsor: Geisinger Clinic. Phase: EARLY_PHASE1. Conditions: Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Hypercholesterolemia

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04058743: Nickel Sensitivity

    Sponsor: Rush University Medical Center. Phase: NA. Conditions: Knee Arthropathy, Allergic Reaction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06457555: Knowledge Levels and Experiences of Intensive Care Nurses on the Prevention of Pressure Sores: Mixed Method

    Sponsor: Burdur Mehmet Akif Ersoy University. Phase: . Conditions: Nurses, Pressure Ulcer, Critical Care

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07451925: Prediction of Postoperative Pain Using Venous Cannulation Pain and Preoperative Anxiety Scores

    Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Preoperative Anxiety, Postoperative Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03965325: FOcUs on Colorectal CAncer oUtcomes: Long-Term Study

    Sponsor: IHU Strasbourg. Phase: . Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05066217: An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

    Sponsor: Epygenix. Phase: PHASE3. Conditions: Lennox Gastaut Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06157840: Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Opioid Use Disorder, Poor Quality Sleep

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07487740: A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants

    Sponsor: Trevi Therapeutics. Phase: PHASE1. Conditions: Healthy Participants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04821089: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

    Sponsor: Ipsen. Phase: PHASE1. Conditions: Moderate to Severe Upper Facial Lines

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02362750: Evaluating Cancer Survivorship Care Models

    Sponsor: George Washington University. Phase: . Conditions: Quality of Life, Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06276491: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

    Sponsor: Xencor, Inc.. Phase: PHASE1. Conditions: Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07236918: The Concert Therapy Pilot Study for Stress Reduction and Wellbeing

    Sponsor: BeHnam KhodaRahmi. Phase: NA. Conditions: Stress Reduction, Psychological Wellbeing, Mental Health, Music Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03478839: Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Generalized Arterial Calcification of Infancy, Autosomal Recessive Hypophosphatemic Rickets Type2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07517575: Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis

    Sponsor: R-Pharm International, LLC. Phase: PHASE2. Conditions: Juvenile Idiopathic Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07528001: Hypno-Breastfeeding Education and Postpartum Outcomes

    Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Postpartum Anxiety

    full page →ctgov ↗
    ← prev
    page 18 of 98
    next →